• Business
    • Global report
  • Regulatory
  • Pharmacovigilance
  • Manufacturing
    • GMP
    • Quality assurance
  • R&D
    • API
    • Excipients
    • Trials
    • Drug Delivery
    • Technology
  • Companies
    • Contract manufacturing
    • Equipment
    • Outsourcing
    • Packaging
    • Supply chain
    • Technology Transfer
  • EIPG Newsletter
    • Technology & Production
    • Regulatory
    • Politics & Business
    • Focus on EU’s Countries
    • News from EIPG
Search
  • Who we are
  • How to use and read
Pharma World
  • Business
    • Global report
  • Regulatory
  • Pharmacovigilance
  • Manufacturing
    • GMP
    • Quality assurance
  • R&D
    • API
    • Excipients
    • Trials
    • Drug Delivery
    • Technology
  • Companies
    • Contract manufacturing
    • Equipment
    • Outsourcing
    • Packaging
    • Supply chain
    • Technology Transfer
  • EIPG Newsletter
    • Technology & Production
    • Regulatory
    • Politics & Business
    • Focus on EU’s Countries
    • News from EIPG
Home Tags Potential safety signals

Tag: potential safety signals

EMA’s view on Pharmacovigilance in 2030

Giuliana Miglierini - 21 January 2020
0

Recent Posts

  • EIPG: 2019 was about Brexit, 2020 was about Covid-19. What will 2021 be about?
  • Hungary: Logistic challenges in the pharma industry due to Covid-19
  • The new European Education Area
  • Regulatory sandboxes to experiment real-world innovation
  • The EU Commission published the new Pharmaceutical Strategy

Latest Updates

  • 2018/04 - December

    2018/04 – December

  • 2018/03 – November

  • 2018/02 – June

  • 2018/01 – May

Subscribe to our newsletter

Translate

NCF – Notiziario Chimico Farmaceutico

RSS NCF

  • Buone notizie per i malati di epatocarcinoma: la combinazione Tecentriq / Avastin di Roche è in grado di prolungare la sopravvivenza globale (OS)
  • Procedura semplificata di prezzo e rimborso per i farmaci equivalenti/biosimilari
  • Radiofarmaci alfa-emittenti di prossima generazione
  • Convalida dei processi termici: termocoppie CAP IT tipo “T” ULTRA-PREMIUM
  • Maxi-accordo nel mondo del pharma sull’asse Italia-Svizzera
© 2020 Tecniche Nuove Spa • Tutti i diritti riservati. Sede legale: Via Eritrea 21 - 20157 Milano. Capitale sociale: 5.000.000 euro interamente versati. Codice fiscale, Partita Iva e Iscrizione al Registro delle Imprese di Milano: 00753480151